Loading...
Market
Public reaction to BMA's stance on Cass Review by end of 2024?
1
Resolution / Starting Odds
Mostly positive • 25%
Mostly negative • 25%
Mixed reactions • 25%
Indifferent • 25%
Public opinion polls and media coverage
Story
BMA to Evaluate Cass Review on Pediatric Gender Transition Treatment, Despite High Court Endorsement
Jul 31, 2024, 03:44 PM
The British Medical Association (BMA) has announced it will undertake an evaluation of the Cass Review, which found that pediatric gender transition treatment is based on 'remarkably weak evidence.' This decision follows a recent vote by the BMA's Council in favor of a motion to publicly critique the review. The announcement comes shortly after the High Court described the Cass Review as 'the best and most up to date scientific evidence available.' Additionally, the High Court ruled that ministers have the right under the 1968 Medicines Act to make decisions based on the Cass Review. The BMA's move has sparked significant debate within the medical community.
View original story
Similar markets
BMA wins and NHS halts PA recruitment • 25%
BMA wins but no change in NHS policy • 25%
GMC wins and NHS continues PA recruitment • 25%
GMC wins but NHS modifies PA recruitment policy • 25%
Strike • 25%
Work-to-rule • 25%
No Action • 25%
Other • 25%
Public backlash • 33%
Public support • 33%
Public indifference • 33%
Supportive • 25%
Opposed • 25%
Neutral • 25%
Divided • 25%
Mostly supportive • 25%
Mostly opposed • 25%
Mixed reactions • 25%
Indifferent • 25%
New budget increase agreed • 25%
No change in budget • 25%
Temporary suspension of industrial action • 25%
Other outcome • 25%
Support the ruling • 25%
Oppose the ruling • 25%
Neutral stance • 25%
Other • 25%
Majority support the outcome • 25%
Majority oppose the outcome • 25%
Mixed reactions • 25%
Indifferent • 25%
